RIS Rx Extends Triple A Platform with Real-Time Monitoring Backed by PharmD-to-PharmD Engagement

RIS Rx Extends Triple A Platform with Real-Time Monitoring Backed by PharmD-to-PharmD Engagement

August 13, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
Press Releases
Get GTN Insights by Email
Inside the RIS Rx Security and Data Privacy Program: 5 Safeguards Every Manufacturer Should Verify
Inside the RIS Rx Security and Data Privacy Program: 5 Safeguards Every Manufacturer Should Verify

August 10, 2026

Matthew Webster
Matthew Webster Chief Information Security Officer
Careen Martin
Careen Martin Chief Compliance & Privacy Officer
Our People
Diann Dalton Potestio On The Hidden Cost of Waiting
Diann Dalton Potestio On The Hidden Cost of Waiting

June 17, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
GTN Insights
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight
Pharmacy Copay Misuse: The Multi-Billion Dollar Issue Hiding In Plain Sight

June 4, 2026

Stephen Hom
Stephen Hom Co-founder & COO
GTN InsightsPharmacy-based Leakage
GTN Leakage Is A Solvable Crisis. Learn Why On Our Podcast.
GTN Leakage Is A Solvable Crisis. Learn Why On Our Podcast.

May 11, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
GTN Insights
Welcoming Tom Doyle to the RIS Rx Family
Welcoming Tom Doyle to the RIS Rx Family

April 23, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
Our PeopleOur Story
Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.
Alternative Funding Programs (AFPs) Are Getting the Headlines. But Your PAP Has a Bigger Problem.

April 13, 2026

Stephen Hom
Stephen Hom Co-founder & COO
AFP-based leakageGTN Insights
What You Need to Know About the $90B Leakage Problem
What You Need to Know About the $90B Leakage Problem

April 1, 2026

Stephen Hom
Stephen Hom Co-founder & COO
GTN Insights
RIS Rx Introduces New Brand Platform: GTN Revenue Protection
RIS Rx Introduces New Brand Platform: GTN Revenue Protection

March 18, 2026

Chase Carpenter
Chase Carpenter VP, Marketing
Our StoryPress Releases
From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale
From Leakage to Leverage: How RIS Rx Is Redefining Patient Affordability at Scale

February 17, 2026

Gerard Rivera
Gerard Rivera Co-founder & CEO
GTN Insights

Learn why the world‘s top pharmaceutical companies trust RIS Rx to protect their patients and improve GTN.